UNSPSC 51181577: Zopolrestat

This classification denotes an aldose reductase inhibitor with the molecular formula C19H12F3N3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1PV3S9WP3D, chemically known as 3,4-dihydro-4-oxo-3-((5-trifluoromethyl-2-benzothiazolyl)methyl)-1-phthalazine acetic acid but generally known as zopolrestat, which bears US NIH Compound Identifier 1613. European Medicines Agency schedules Zopolrestat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00189MIG.

UNSPSC 51181577 Zopolrestat is a Commodity code representing specialized pharmaceutical products. State and local governments procure zopolrestat and related generic pharmaceuticals through cooperative purchasing alliances and multistate agreements rather than individual agency solicitations. The work involves supplying finished pharmaceutical products that meet FDA requirements, current Good Manufacturing Practices (cGMP), and Drug Supply Chain Security Act (DSCSA) compliance, with vendors required to maintain relationships with authorized wholesalers and provide detailed product information including National Drug Codes, SKUs, and manufacturing locations. Issuing bodies are primarily state purchasing offices and multistate cooperative purchasing alliances serving state agencies, local government facilities, and participating jurisdictions.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP in January 2026 for generic multi-source pharmaceuticals and OTC products to serve participating state and local government facilities including Oregon. The RFP (S1070000015802), due March 26, 2026, seeks manufacturers to establish multiple-award contracts effective July 1, 2026, with pricing weighted at 75 percent of the evaluation and compliance with EDI capability, administrative fee format, and pricing flexibility structures comprising the remainder. Vendors must maintain workers' compensation and commercial general liability insurance of $5 million per occurrence, network security and privacy liability of $2 million, and professional liability of $2 million. The contract term runs two years for new responders with optional extensions at MMCAP's discretion, and vendors are subject to performance penalties ranging from $200 to $1,500 per violation for late reporting, missed onboarding deadlines, or improper class-of-trade denials.